The patient stated that he had a follow-up with the primary care physician related to the skin irritation and the bump.On december 28, 2020, the patient followed-up with the implanting clinician.On this date, the implanting clinician performed imaging and determined that migration had occurred.On december 30, 2020, the implanting clinician performed a revision.The implanting clinician performed a small incision and trimmed the sandshark wing down.The physician also irrigated the site and stitched it shut with a double layer of sutures.There was no infection and no loss of therapy.However, antibiotics were prescribed as a preventative measure.The patient is doing well after the procedure and has a follow-up the week of january 8, 2020.Stimwave conducted a review of sterilization and packaging records for the respective product lot.Stimwave has confirmed that the product was delivered sterile, validated sterilization parameters were used, and sterile barriers were verified to be intact following packaging.Based on this information, the migration/skin irritation were confirmed/replicated.There is no evidence that the product did not meet specifications, and the stimulator is used to treat pain.The cause of the migration/skin irritation is unknown/no problem found.A potential cause of the event may be device placement at inadequate depth too near to the skin.
|